Current State of Clostridium difficile Treatment Options

Recent reports of reduced response to standard therapies for Clostridium difficile infection (CDI) and the risk for recurrent CDI that is common with all currently available treatment agents have posed a significant challenge to clinicians. Current recommendations include metronidazole for treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Venugopal, Anilrudh A., Johnson, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388023/
https://www.ncbi.nlm.nih.gov/pubmed/22752868
http://dx.doi.org/10.1093/cid/cis355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388023/
https://www.ncbi.nlm.nih.gov/pubmed/22752868
http://dx.doi.org/10.1093/cid/cis355

Ejemplares similares